|Year : 2021 | Volume
| Issue : 4 | Page : 823-824
Central serous chorioretinopathy in a silicone oil-filled eye
Subhakar Reddy, Mudit Tyagi, Mahima Jhingan, Jay Chhablani
Smt Kanuri Santhamma Center for Vitreo-Retinal Diseases, L V Prasad Eye Institute, Hyderabad, Telangana, India
|Date of Submission||23-Nov-2020|
|Date of Acceptance||04-May-2021|
|Date of Web Publication||09-Oct-2021|
Dr. Mudit Tyagi
Smt Kanuri Santhamma Center for Vitreo-retina Services, L. V. Prasad Eye Institute, Hyderabad - 500 034, Telangana
Source of Support: None, Conflict of Interest: None
Keywords: Central serous chorioretinopathy, silicone oil, vitreoretinal surgery
|How to cite this article:|
Reddy S, Tyagi M, Jhingan M, Chhablani J. Central serous chorioretinopathy in a silicone oil-filled eye. Indian J Ophthalmol Case Rep 2021;1:823-4
|How to cite this URL:|
Reddy S, Tyagi M, Jhingan M, Chhablani J. Central serous chorioretinopathy in a silicone oil-filled eye. Indian J Ophthalmol Case Rep [serial online] 2021 [cited 2021 Oct 28];1:823-4. Available from: https://www.ijoreports.in/text.asp?2021/1/4/823/327671
A 45-year-old healthy male with a visual acuity of counting finger 1 m underwent a 25 gauge pars plana vitrectomy along with IOL explantation and a silicone oil endotamponade for posteriorly dislocated IOL and rhegmatogenous retinal detachment. At 1 week follow-up, the vision in the left eye had improved to 20/200. A retinal evaluation of the left eye showed attached retina under silicone oil. However, an elevated serous detachment of neurosensory retina was noted at this visit [Figure 1]a and [Figure 1]b. Optical coherence tomography (OCT) of the left eye showed a large dome-shaped serous detachment of neurosensory retina [Figure 2]a. Fundus fluorescein angiography of the left eye showed a characteristic expanding dot-like pattern of leak [Figure 2]b and [Figure 2]c superonasal to fovea suggestive of CSCR. All systemic risk factors were ruled out after taking meticulous history.
|Figure 1: (a) Color fundus photograph of the left eye showing silicone oil-filled eye with an elevated serous detachment of neurosensory retina (yellow arrow) at macula better appreciated in red-free photograph Figure 1b (outline)|
Click here to view
|Figure 2: (a) OCT of the left eye at postoperative 1-week follow-up showing elevated dome-shaped serous detachment of neurosensory retina (yellow arrow). FFA of the left eye early (b) and late arteriovenous phase (c) showing expanding dot pattern (yellow arrow) of leakage with optic disc leakage|
Click here to view
In this case, topical corticosteroids were the only factor that we could attribute to be a risk factor for CSCR. Therefore, topical corticosteroids were discontinued and were substituted with topical non-steroidal anti-inflammatory agents (NSAIDs). At 2 months, the BCVA had improved to 20/40. The serous detachment had regressed on OCT suggestive of resolution of CSCR [Figure 3]a and [Figure 3]b. Silicone oil removal along with secondary glued IOL implantation was done subsequently.
|Figure 3: (a and b) Fundus photograph and OCT of the left eye, respectively, at 2-month follow-up showing complete resolution of serous detachment at macula|
Click here to view
| Discussion|| |
The main risk factors for CSCR include exogenous corticosteroid usage or endogenous hypercortisolism, type A personality, and pregnancy.,, Corticosteroids through various routes (oral, intravenous, periocular, or intranasal) are known to cause CSCR.,,,, Chang et al. described an association between topical ophthalmic corticosteroids and CSCR. Moreno-López et al. reported a case of persistent subretinal fluid due to central serous chorioretinopathy (the patient had used topical steroids for 5 weeks) after 5 months of retinal detachment surgery; however, authors did not contribute the occurrence of CSCR to topical steroids. Therefore, it may be prudent to consider discontinuation of the offending risk factor in such cases.
This case describes a rare occurrence of CSR in a silicone oil-filled eye which resolved spontaneously after 2 months.
Financial support and sponsorship
Support provided by Hyderabad Eye Research Foundation, Hyderabad, India.
Conflicts of interest
There are no conflicts of interest.
| References|| |
Nicholson B, Noble J, Forooghian F, Meyerle C. Central serous chorioretinopathy: Update on pathophysiology and treatment. Surv Ophthalmol 2013;58:103-26.
Liew G, Quin G, Gillies M, Fraser-Bell S. Central serous chorioretinopathy: A review of epidemiology and pathophysiology. Clin Exp Ophthalmol 2013;41:201-14.
Daruich A, Matet A, Dirani A, Bousquet E, Zhao M, Farman N, et al
. Central serous chorioretinopathy: Recent findings and new physiopathology hypothesis. Prog Retin Eye Res 2015;48:82-118.
Tsai D-C, Chen S-J, Huang C-C, Chou P, Chung C-M, Chan W-L, et al
. Risk of central serous chorioretinopathy in adults prescribed oral corticosteroids: A population-based study in Taiwan. Retina 2014;34:1867-74.
Grixti A, Kumar V. Steroid induced central serous chorioretinopathy in giant cell arteritis. Case Rep Ophthalmol Med 2013;2013:924037.
Baumal CR, Martidis A, Truong SN. Central serous chorioretinopathy associated with periocular corticosteroid injection treatment for HLA-B27 associated iritis. Arch Ophthalmol 2004;122:926-8.
Kleinberger AJ, Patel C, Lieberman RM, Malkin BD. Bilateral central serous chorioretinopathy caused by intranasal corticosteroids: A case report and review of the literature. Laryngoscope 2011;121:2034-7.
Araki T, Ishikawa H, Iwahashi C, Niki M, Mitamura Y, Sugimoto M, et al
. Central serous chorioretinopathy with and without steroids: A multicenter survey. PLoS One 2019;14:e0213110.
Chang YS, Weng SF, Chang C, Wang JJ, Wang JY, Jan RL. Associations between topical ophthalmic corticosteroids and central serous chorioretinopathy: A Taiwanese population-based study. Invest Ophthalmol Vis Sci 2015;56:4083-9.
Moreno-López M, Pérez-López M, Casas-Llera P, Jarrín E, Muñoz-Negrete FJ. Persistent subretinal fluid due to central serous chorioretinopathy after retinal detachment surgery. Clin Ophthalmol 2011;5:1465-7.
[Figure 1], [Figure 2], [Figure 3]